124 related articles for article (PubMed ID: 16091048)
1. Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol.
Kremer L; de Chastellier C; Dobson G; Gibson KJ; Bifani P; Balor S; Gorvel JP; Locht C; Minnikin DE; Besra GS
Mol Microbiol; 2005 Aug; 57(4):1113-26. PubMed ID: 16091048
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the essential FAS II β-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii.
Belardinelli JM; Morbidoni HR
Mol Microbiol; 2012 Nov; 86(3):568-79. PubMed ID: 22994892
[TBL] [Abstract][Full Text] [Related]
4. Electrospray ionization-tandem mass spectrometry analysis of the mycolic acid profiles for the identification of common clinical isolates of mycobacterial species.
Song SH; Park KU; Lee JH; Kim EC; Kim JQ; Song J
J Microbiol Methods; 2009 May; 77(2):165-77. PubMed ID: 19318047
[TBL] [Abstract][Full Text] [Related]
5. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
6. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
7. Understanding the action of INH on a highly INH-resistant Mycobacterium tuberculosis strain using Genechips.
Fu LM; Shinnick TM
Tuberculosis (Edinb); 2007 Jan; 87(1):63-70. PubMed ID: 16890025
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
9. Characterization of mycobacterial triacylglycerols and monomeromycolyl diacylglycerols from Mycobacterium smegmatis biofilm by electrospray ionization multiple-stage and high-resolution mass spectrometry.
Purdy GE; Pacheco S; Turk J; Hsu FF
Anal Bioanal Chem; 2013 Sep; 405(23):7415-26. PubMed ID: 23852148
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
11. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests.
Rando DG; Doriguetto AC; Tomich de Paula da Silva CH; Ellena J; Sato DN; Leite CQ; Varanda EA; Ferreira EI
Eur J Med Chem; 2006 Oct; 41(10):1196-200. PubMed ID: 16828526
[TBL] [Abstract][Full Text] [Related]
12. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
[TBL] [Abstract][Full Text] [Related]
13. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis.
Parrish NM; Kuhajda FP; Heine HS; Bishai WR; Dick JD
J Antimicrob Chemother; 1999 Feb; 43(2):219-26. PubMed ID: 11252327
[TBL] [Abstract][Full Text] [Related]
15. Monolayers of the lipid derivatives of isoniazid at the air/water interface and the formation of self-assembled nanostructures in water.
Jin Y; Chen S; Xin R; Zhou Y
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):229-35. PubMed ID: 18329860
[TBL] [Abstract][Full Text] [Related]
16. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
[TBL] [Abstract][Full Text] [Related]
18. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
Sriram D; Yogeeswari P; Yelamanchili Priya D
Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
[TBL] [Abstract][Full Text] [Related]
19. The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis.
Sacco E; Covarrubias AS; O'Hare HM; Carroll P; Eynard N; Jones TA; Parish T; Daffé M; Bäckbro K; Quémard A
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14628-33. PubMed ID: 17804795
[TBL] [Abstract][Full Text] [Related]
20. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
Shenai S; Rodrigues C; Mehta A
Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]